‘We don’t agree’ on drug pricing policy, FDA chief tells biotech leaders

Stat News

7 June 2023 - The drug industry has spent the past year speaking against new mechanisms that could limit how much governments or insurers pay for certain new medicines. Robert Califf, the FDA chief, walked on stage Wednesday and told a crowd of biotech leaders that drug costs needed fixing.

“We don’t agree,” said Califf, referring to a conversation he had backstage with Ted Love, the new chair of the Biotechnology Innovation Organization. “I think the prices of drugs are too high in the US.”

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing